Xilio Therapeutics, Inc. (XLO:NASDAQ) closed at $8.08 on November 13, 2026, down 2.00% on the day. The stock trades 28.5% below its 52-week high of $11.30 and 24.8% above its 52-week low of $6.47. Over the past year, it lost 20.3%. Xilio Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, XLO closed higher on 105 days (42%). Its best day was May 14, 2026 (+13.53%) and its worst was November 13, 2025 (-9.18%). The stock moved 10% or more in a single session 2 times.
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.
Find more stocks like XLO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.